A North Carolina Coalition Pushes for Inclusive Clinical Trials
An analysis of 32,000 individuals who participated in new drug trials in the US during 2020 showed that only 8% were Black, 6% Asian, 11% Hispanic and 30% were age 65 and older – showing the underrepresentation of diverse populations in clinical trials.